Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guideline Platform
  3. Gynaecology
  4. Back
  5. Gynaecology guidelines
  6. Minimising urinary tract injury at gynaecological surgery for benign disease (1038)
Announcements and latest updates

Right Decision Service newsletter: September 2024

Welcome to the Right Decision Service (RDS) newsletter for September 2024.

1.Business case for permanent provision of the Right Decision Service from April 2025 onwards

This business case has now been endorsed by the HIS Board and will shortly be submitted to Scottish Government.

2. Management of RDS support tickets

To balance increasing demand with available capacity and financial resource, the RDS team and Tactuum are now working together to  implement closer management of support tickets. As a key part of this, we want to ensure clear, timely and consistent communication with yourselves as requesters.  

Editors will now start seeing new messages come through in response to support ticket requests which reflect this tightening up and improvement of our processes.

Key points to note are:

2.1 Issues confirmed by the RDS and Tactuum teams as meeting the critical/urgent and high priority criteria will continue to be prioritised and dealt with immediately.

Critical/urgent issues are defined as:

  1. The Service as a whole is not operational for multiple users. OR
  2. Multiple core functions of the Service are not operational for multiple users.

Example – RDS website outage.

Please remember to email ann.wales3@nhs.scot and his.decisionsupport@nhs.scot with any critical/urgent issues in addition to raising a support ticket.

High priority issues are defined as:

  1. A single core function of the Service is not operational for multiple users. OR:
  2. Multiple non-core functions of the Service are not operational for multiple users.

Example – Build to app not working.

2.2 Support requests that are outwith the warranty period of 12 weeks since the software was originally developed will not be automatically addressed by Tactuum. The RDS team will consider these requests for costed development work and will obtain estimate of effort and cost from Tactuum for priority issues.

2.3 Support tickets for technical issues that are not classified as bugs will not be automatically addressed by Tactuum. The definition of a bug is ‘a defect in the software that is at variance with documented user requirements.’  Issues that are not bugs will also be considered for costed development work.

The majority of issues currently in support tickets fall into category 2 or 3 above, or both.

2.4 Non-urgent requests that require a deployment (i.e a new release of RDS) will normally be factored into the next scheduled release (currently end of Nov 2024 and end of Feb 2025) unless by special agreement with the RDS team.

Please note that we plan to move in the new year to a new system whereby requests all come to an RDS support portal in the first instance and are triaged from there to Tactuum when appropriate.

We will be organising a webinar in a few weeks’ time to take you through the details of the current support processes and criteria.

3. Next scheduled deployment.

The next scheduled RDS deployment will take place at the end of November 2024.  We are reviewing all outstanding support tickets and feature requests along with estimates of effort and cost to determine which items will be included in this deployment.

We will update you on this in the next newsletter and in the planned webinar about support ticket processes.

4. Contingency arrangements for RDS

Many thanks to those of you who attended our recent webinar on the contingency arrangements being put in place to prevent future RDS outages as far as possible and minimise impact if they do occur.  Please contact ann.wales3@nhs.scot if you would like a copy of the slides from this session.

5. Transfer of CKP pathways to RDS

The NES clinical knowledge pathway (CKP) publisher is now retired and the majority of pathways supported by this tool have been transferred to the RDS. Examples include:

NHS Lothian musculoskeletal pathways

NHS Fife rehabilitation musculoskeletal pathways

NHS Tayside paediatric pathways

6. Other new RDS toolkits

Include:

Focus on frailty (from HIS Frailty improvement programme)

NHS GGC Money advice and support

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

To go live imminently:

  • Focus on dementia
  • NHS Lothian infectious diseases toolkit
  • Dumfries and Galloway Adult Support and Protection procedures
  • SIGN guideline – Prevention and remission of type 2 diabetes

 

7. Evaluation projects

We have recently analysed the results of a survey of users of the Scottish Palliative Care Guidelines toolkit.  Key findings from 61 respondents include:

  • Most respondents (64%) are frequent users of the toolkit, using it either daily or weekly. A further 25% use it once or twice per month.
  • 5% of respondents use the toolkit to deliver direct patient care and 82% use it for learning
  • Impact on practice and decision-making was rated as very high, with 80% of respondents rating these at a 4-5 on a 5 point scale.
  • Impact on time saving was also high, with 74% of respondents rating it from 3-5.
  • 74% also reported that the toolkit improved their knowledge and skills, rating these at 4-5 on the Likert scale

Key strengths identified included:

  • The information is useful, succinct, and easy to understand (31%).
  • Coverage is comprehensive (15%)
  • All information is readily accessible in one place and users value the offline access via mobile app (15%)
  • Information is reliable, evidence-based and up to date (13%)

Users highlighted key areas for improvement in terms of navigation and search functionality. The survey was very valuable in enabling us to uncover the specific issues affecting the user experience. Many of these can be addressed through content management approaches. The issues identified with search results echo other user feedback, and we are costing improvements with a view to implementation in the next RDS deployment.

8.RDS High risk prescribing (polypharmacy) decision support embedded in Vision and EMIS primary care E H R systems

This decision support software, sponsored by Scottish Government Effective Prescribing and Therapeutics Division,  is now available for all primary care clinicians across NHS Tayside. Board-wide implementation is also planned for NHS Lothian, and NHS GGC, NHS Ayrshire and Arran and NHS Dumfries and Galloway have initial pilots in progress. The University of Dundee has been commissioned to evaluate impact of this decision support software on prescribing practice.

9. Video tutorials for RDS editors

Ten bite-size (5 mins or less) video tutorials for RDS editors are now available in the “Resources for providers of RDS tools” section of the RDS.  These cover core functionality including Save and preview, content page and media management, password management and much more.

10. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Wednesday 23rd October 4-5 pm
  • Tuesday 29th October 11 am -12 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

 

Minimising urinary tract injury at gynaecological surgery for benign disease (1038)

Warning

Objectives

To provide guidance for those undertaking benign gynaecological procedures where there is a risk of urinary tract injury.

Scope

All healthcare professionals undertaking gynaecological procedures where there is a risk of urinary tract injury

Please report any inaccuracies or issues with this guideline using our online form

Background and rates of injury

Injury to the urinary tract at benign gynaecological surgery is uncommon as defined by the RCOG (1).

A systematic analysis found the rate of urinary tract injury in laparoscopic surgery for benign  gynaecological operations to be 3.3/1000.

Urinary tract injury is however more common at hysterectomy. RCOG consent advice (3) recommends quoting a rate of urinary tract injury of 7/1000 for abdominal hysterectomy procedures.

A retrospective study of almost 1000 hysterectomies for benign conditions in NHSGGC found the following rates of urinary tract injury (presented at ESGE 2018)

Rate of injury to bladderRate of injury to uterer
Laparoscopic hysterectomy1.3%1.9%
LAVH1%3%
Open hysterectomy0.8%0.6%

A retrospective analysis performed by the BSGE found a ureteric injury rate of 0.5% in excision of deep infiltrating endometriosis at endometriosis centres in the UK with 9.2% of procedures requiring stent insertion. (4)

Bladder injury is typically by incision of the bladder and is usually recognised at operation. Ureteric injury can occur by angulation, crushing, resection, division or damage by heat or devascularisation and may be less likely to be unrecognised (5). Ureteric injury may present late with urinary leakage being delayed after thermal or vascular damage with no apparent injury at the time of operation.

Pre-operative considerations

Alternatives to surgery should be discussed with each patient who is considering surgery.

The consent process should note any factors that may increase the rate of urological tract injury and this should be explicit in the consent process, such as but not exclusively:

Patient factors: BMI, previous pelvic surgery, previous caesarean section.

Pathology factors: pelvic abscess or endometriosis, malignancy, known hydronephrosis.

Pre-operative imaging to exclude hydronephrosis or hydroureter should be performed if there is disease suspected in the lateral pararectal fossa or a large pelvic mass. If hydronephrosis is confirmed on imaging then renography with MAG3 scanning should be performed to assess renal function. Pre-operative stent insertion should be considered and referral to urological colleagues made if hydronephrosis is confirmed or if disease processes involve the ureter.

Pre-operative request for urological opinion should be sought in these patients:

  1. Previous ureterolysis when operating in the lateral pararectal fossa is anticipated.
  2. Known hydronephrosis
  3. Known disease involving the ureter. Specialist urological radiology reporting may be needed in complex pathology.

Intraoperative considerations

The urinary bladder should be emptied to reduce the risk of urinary tract injury.

There is a difference in approach between gynaecologists and urologists when operating in proximity to the ureter. Gynaecologists do not use ureteric stents routinely when operating within the lateral pararectal space. It is recognised common gynaecological practice to visually identify the ureter prior to clamping and ligating pedicles (or using instruments for vessel sealing) or applying surgical heat at operation. Ureterolysis is performed by gynaecologists for up to 10cm of ureteric length without stent insertion. Surgeons should be familiar with the thermal effects of any energy device employed during surgery (6)

Ureteric stenting may reduce ureteric injury in two ways. Firstly it may help to identify the ureter if there is difficulty in visual identification. Secondly stenting may reduce ureteric injury leading to leakage when there has potentially been thermal or vascular damage to the ureter. Stenting may reduce the risk of hydronephrosis due to angulation injury. However stenting may alter the anatomy of the lateral pararectal fossa by straightening the ureter to a more medial position.

Urological colleagues are always happy to assist with stent insertion. Requests for an intraoperative urological opinion should be sought in these patients:

  1. If the ureter cannot be identified. Insertion of a temporary ureteric catheter may help a gynaecologist who is competent with their use to identify the ureter but may not protect against later ureteric leakage if there has been damage to the vascular supply to the ureter or thermal injury to it.
  2. If there is a bladder injury and the gynaecological surgeon does not have expertise to close the bladder.
  3. Any bladder injury where injury to the trigone is suspected.
  4. Any suspected ureteric injury.

Post-operative consideration

In patients who experience a urological complication of gynaecological surgery their operating gynaecology consultant should be the point of contact for urological colleagues.

A follow up appointment should be requested with the operating gynaecology surgeon via their secretary on patient discharge.

Editorial Information

Last reviewed: 14/07/2022

Next review date: 14/07/2027

Author(s): Chris Hardwick.

Version: 1

Approved By: Gynaecology Clinical Governance Group

Document Id: 1038

References

1. RCOG Clinical Governance Advice No. 7
2. Wong, Jacqueline M. K. MD; Bortoletto, Pietro MD; Tolentino, Jocelyn MD, MPH; Jung, Michael J. MD, MBA; Milad, Magdy P. MD, MS Obstetrics & Gynecology. 131(1):100-108, January 2018
3. Abdominal Hysterectomy for Benign Conditions (Consent Advice No. 4) (rcog.org.uk)
4. e018924.full.pdf (bmj.com)
5. Minas V, Gul N, Aust T, Doyle M, Rowlands D. Urinary tract injuries in laparoscopic gynaecological surgery; prevention, recognition and management. The Obstetrician & Gynaecologist 2014;16:19–28.
6. Bentham GL, Preshaw J. Review of advanced energy devices for the minimal access gynaecologist. The Obstetrician & Gynaecologist 2021;23:301–9. https://doi.org/10.1111/tog.12774